Investigates anti-quorum sensing compounds in marine-derived actinomycete to combat resistant infections, suggesting therapeutic potential.
Quorum sensing inhibitors (QSIs) can inhibit the quorum sensing regulated physiological functions of bacteria and might be useful in drug-resistant bacterial infection therapy. The culture medium of a mangrove derived actinobacterium Streptomyces chumphonensis HN2-56, which exhibiting higher anti-quorum sensing activity, was optimized in this study. The results showed that the GS medium was the most favourable medium for the bioactivity of HN2-56 and that the content of soluble starch in the GS medium had a significant impact on the yield of metabolites. By culturing under the optimized condition (soluble starch 40 g/L, KNO3 4 g/L, salinity of 0 and pH 6.5), both metabolites production and anti-quorum sensing activity of HN2-56 against the purple pigment (violacein) production of Chromobacterium violaceum 12472 were significantly increased (41.8% and 177.9%, respectively). Five pure compounds were obtained from the extract of HN2-56 and identified as 2,2-[bis-4-(2,3-dihydroxypropane) phenyl] propane (1), bisphenol A (2), 5-(2-methylphenyl)-4-pentenoic acid (3), 3-methyl-1H-indole-2-carboxylate (4) and dibutyl phthalate (5). Among them, compounds 2 and 3 showed anti-quorum sensing activity against C. violaceum 12472 and anti-biofilm activity against Staphylococcus aureus 43300. These findings indicated that S. chumphonensis HN2-56 should be a promising candidate for QSIs with potential anti-quorum sensing application. Although BPA was detected in the HN2-56 extract, experimental contamination could not be excluded because of the ubiquitous presence of BPA in plasticware and laboratory reagents.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: